Predictive Patterns Merges with Visible Bytes Software
Predictive Patterns Software, which was formed last spring to market the GeneLinker software products originally developed by Molecular Mining, announced that it will merge with Visible Bytes Software, a provider of software services for the medical industry.
The combined entity will do business under the name of Improved Outcomes Software. Improved Outcomes will assume the business, personnel, and management teams of both companies, and will provide software products and services in the bioinformatics, image-guided surgery, and information technology fields, the companies said. The new company will continue to sell the GeneLinker gene expression analysis software.
Siemens, Biomax Collaborate on Gene Expression Modeling
Siemens and Biomax Informatics said in August that they have entered into a collaboration in the area of gene expression modeling and simulation.
Under the terms of the agreement, Siemens will contribute its BioSim software, which “recognizes interrelated dependencies within gene expression data,” the company said. The companies said they will use Biomax’s BioXM gene expression analysis software to analyze correlations uncovered in the simulation within a biological context.
Fujitsu BioIT Group Changes Name
Fujitsu’s BioIT Group, a division of Fujitsu America, will now be known as the BioSciences Group.
“The BioSciences Group is not purely an IT organization. Our goal is to make research more effective — not just to ‘sell boxes,’” said Yasunori Katsumata, vice president of Fujitsu America and head of the BioSciences Group, in a statement.
The BioIT group was formed earlier this year to help build a sales and marketing strategy for the company’s life science products in the US [BioInform 05-03-04].
Michael McManus, vice president of the BioIT group, will retain that title in the BioSciences Group.
Lion Signs on Two Cheminformatics Partners
Lion said in August that it has established two new partnerships to extend its reach into cheminformatics.
The company said it will partner with BioByte, a company that focuses on QSAR (quantitative structure activity relationship) analysis to integrate the company’s cLogP hydrophobicity calculation software into Lion’s LeadNavigator product.
Lion will also work with ChemNavigator to develop custom software modules that will be integrated into LeadNavigator. Lion will also serve as the exclusive global reseller of ChemNavigator’s database subscriptions, products, and services.
Blueprint Asia Collaborates with Novartis Institute on Dengue Fever
The Blueprint Initiative Asia, housed at the National University of Singapore, said in August that it is collaborating with the Novartis Institute for Tropical Diseases on a research project for dengue fever.
Blueprint Asia will assemble and curate known protein interactions relevant to the biology of the dengue virus, and will enter this data into the Biomolecular Interaction Network Database.
Biobase to Reorganize Marketing Structure
Biobase of Wolfenb ttel, Germany, said that it plans to change its North American marketing structure.
Until now, New York-based bioinformatics firm Cognia has distributed Biobase’s products in North America. In the future, Biobase said it plans to “greatly increase its marketing activities in this region and distribute all products itself along with Cognia.”
Further details were not provided.
Ocimum Taps European Distributor
Ocimum Biosolutions said that it has signed a deal with Science-Partners of Oxford, UK, to market and distribute Ocimum’s LIMS and bioinformatics products in the UK and North European markets.
Financial terms of the agreement were not provided.
NIGMS Awards $15M to Quantitative Bio Center
The National Institute of General Medical Sciences said that it will award $3 million this year to a new quantitative biology center it is establishing at Princeton University. The center, the fifth so-called Center of Excellence in Complex Biomedical Systems Research that NIGMS has funded, will be led by David Botstein.
NIGMS said it expects to award the center a total of $14.8 million over five years.
NIGMS said that a “key feature” of the center will be the development of computational methods to model complex biological systems based on large quantities of experimental data. The center will make all its data and analysis tools freely available.